Quantcast

Latest Regenerative medicine Stories

2014-07-24 16:24:57

COSTA MESA, Calif., July 24, 2014 /PRNewswire/ -- Now available is a stem cell therapy that is incredibly close to home. Rehealth Regenerative Therapies, located in Guadalajara, Mexico, is offering athletes and other physically active people a new health option: stem cell therapies for sports injuries. Regardless of age, countless patients suffer from joint and muscle injuries due to professional or amateur sport activities, such as muscle tears, torn rotator cuff, tennis elbow, and...

2014-07-23 23:13:54

Many current regenerative medicine trials are based on heterologous stem cell transplantation, in which stem cells multiplied from one type of organ or tissue are transferred to treat diseases, disorders, or injuries in a different type of organ or tissue. Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) continues to develop technologies that could allow as well natural, homologous stem cell transplantation therapies for more human organs and tissues. Boston, MA (PRWEB) July 23,...

2014-07-21 12:24:48

PHILADELPHIA, July 21, 2014 /PRNewswire-USNewswire/ -- The Board of Directors of the Osteo Science Foundation has awarded its inaugural four research grants, totaling close to $200,000, to researchers at Columbia University, Indiana University, Rutgers University and UCLA. The research projects focus on applied developments and treatment concepts in regenerative medicine for clinical application in Oral, Cranial and Maxillofacial surgery. (Photo:...

2014-07-17 16:25:49

NEW YORK, July 17, 2014 /PRNewswire/ -- According to a new market research report published by Transparency Market Research "Regenerative Medicine (Bone and Joint) Market (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global regenerative medicine...

2014-07-17 08:30:21

SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that it has filed an Investigational New Drug application (IND) with the United States Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte's VC-01(TM) product candidate, a stem...

2014-07-15 08:29:38

COLUMBIA, Md., July 15, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced enrollment of the first patient in a U.S. Phase IV clinical trial (NCT02021279; www.clinicaltrials.gov) evaluating the safety and long-term effectiveness of ACell's MatriStem® Pelvic Floor Matrix device as compared to native tissue repair for the treatment of pelvic organ prolapse....

2014-07-10 12:30:00

SAN BRUNO, Calif., July 10, 2014 /PRNewswire/ -- Far from being sharply divided, the American people are in broad support of more stem cell research, according to the results of an online survey released today by Cord Blood Registry® (CBR®) to coincide with National Cord Blood Awareness Month. http://photos.prnewswire.com/prnvar/20140709/125951 The poll included responses from 1,130 individuals to reveal: their belief in the need for continued research to rapidly bring stem cell therapies...

2014-07-09 12:30:16

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Induced Pluripotent Stem Cells : Global Marketshttps://www.reportbuyer.com/product/2212008/Induced-Pluripotent-Stem-Cells--Global-Markets.html This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field and market segments are identified, and market sizes...

2014-07-08 08:32:11

SAN DIEGO, July 8, 2014 /PRNewswire/ -- ViaCyte, Inc. ("ViaCyte"), a privately held regenerative medicine company developing a cell therapy for treatment of type I diabetes, today announced it has received International Standards Organization (ISO) 13485:2003 certification, an internationally recognized quality standard for medical devices. ViaCyte's certification was awarded by the British Standards Institution (BSI), one of the world's leading certification bodies....

2014-07-03 23:05:17

GIA announces the release of a comprehensive global report on Regenerative Medicine markets. Global market for Regenerative Medicine for Bone and Joint Applications is projected to exceed US$7.9 billion by 2020, driven by aging population and the ensuing rise in bone diseases, growing awareness over the effectiveness of regenerative medicines, and increasing use of non-autograft products by orthopedic physicians. San Jose, California (PRWEB) July 03, 2014 Follow us on LinkedIn –...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related